Unlock the Future of ADC Analytics at the 4th ADC Analytical Development Summit! When: April 2025 Where: Boston The 4th ADC Analytical Development Summit is back, bringing together top minds and innovators to tackle the unique analytical challenges of antibody-drug conjugates. With ADCs becoming more complex and regulatory requirements tightening, this event will be your ultimate guide to mastering […]

As the healthcare industry evolves, patient engagement has become a crucial factor in shaping clinical trials, accelerating regulatory approvals, and improving the overall patient experience. Yet, amidst a challenging funding environment, empowered patients rightfully demanding greater involvement in treatment decisions, and regulatory bodies requiring transparent reporting of patient engagement activities, it has become more critical […]

The 2nd GLP-1-Based Therapeutics Summit is an exclusive gateway to competitive intelligence into the continued potential of cutting-edge GLP-1s for obesity, weight loss, diabetes, and beyond. Join us to hear the latest clinical data on combination therapies to enhance muscle preservation, indication expansion into new areas, and strategies to improve the efficacy, tolerability, and durability of GLP-1s. With […]

The 3rd mRNA Process Development & Manufacturing Summit 2025 returns as Europe’s premier industry-focused forum, dedicated to optimizing process development for mRNA therapeutics and vaccines. This event will address end-to-end process optimisation, regulatory compliance to streamline approvals, while also advancing scalable and cost-efficient manufacturing solutions, to support drug developers in delivering safer and more effective mRNA drugs […]

The 2nd ADC Payload Summit (May 6-8 | Boston, MA) is the first and only conference exclusively focusing on ADC payloads, helping you to reimagine the medicinal chemistry of traditional cytotoxic payloads while scouting the next generation of ADC payload innovations. With novel payload categories such as degraders, RNA polymerase II inhibitors, immunomodulators, gene silences, […]

The ALS Drug Development Summit is the definitive industry-led forum dedicated to advancing breakthroughs in ALS therapeutics. With the field evolving rapidly, recent milestones—such as Insitro’s AI-driven target discovery with Bristol Myers Squibb and Dewpoint Therapeutics’ collaboration with Mitsubishi Tanabe Pharma America on TDP-43 condensate modulators—highlight the momentum in novel drug discovery. Meanwhile, QurAlis’ clinical […]

Following a year of exceptional progress in IBD drug development, fierce competition in clinical trials for Chron’s Disease and Ulcerative Colitis remains high, and it’s time for biopharma to push the boundaries of efficacy and distinguish their therapies amongst the market. Featuring three days of data-driven sessions from 25+ world-class speakers, the 3rd Precision Medicine […]

From molecular glue discovery to the development of degrader-antibody conjugates, pharma is transforming through strategic transactions and by leveraging protein degradation technologies to expand target discovery and drug previously 'undruggable' targets. This provides biotech with the opportunity to understand pharma's targets of interest and the options for increased specificity and selectivity compared to traditional molecules. […]

The 4th GPCR-Targeted Drug Discovery Summit: Transforming the Discovery of Novel GPCR-Targeted Therapies. With positive clinical read outs by Tectonic Therapeutics and recent funding rounds for Confo Therapeutics & Septerna, the potential for novel GPCR drug classes to treat a plethora of diseases grows. Now more than ever, there is a need for the community […]

The 6th Gene Therapy Analytical Development Summit Europe is the leading platform for advancing gene therapy analytics, from IND/IMPD filings to clinical trials and regulatory approvals. As the field moves toward late-stage development, gain industry-focused insights tailored for Europe. Join 24+ experts to tackle characterisation, stability, contamination risks, and comparability across vectors and diseases. Network with biotech, pharma, MHRA, and British Pharmacopoeia to share solutions and shape the future […]

The 3rd Retinal Imaging Biomarkers & Endpoints Summit will bring together leading experts spanning medical directors, researchers, clinical, and imaging scientists from more than 30 organizations spearheading ophthalmic development with deep learning systems and sophisticated AI imaging technologies. It’s here they will explore the latest advancements in retinal imaging, biomarkers, and endpoints for ophthalmic drug […]

Current limitations across pricing, coverage, and payment frameworks are lasering out and hindering global access to many approved cell and gene therapies (CGTs). The Cell & Gene Therapy Pricing & Reimbursement Summit is here to change that. Returning for its 2nd edition, this unique summit will share real-world case studies of success and setback in […]

Join the 4th Circular & Self-Amplifying RNA Therapeutics Summit! Unleashing the Next Generation of RNAs for Widespread Therapeutic Applications With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self-amplifying RNAs to provide improved stability, durability, longevity and efficacy […]

Accelerating the Route to Commercialization with Robust Potency Assay Development Following a challenging year in the gene therapy field, the 3rd Gene Therapy Potency Assay Summit returns at a crucial time when drug developers increasingly recognize that a robust potency assay is fundamental to both clinical success and commercial viability. As regulatory expectations continue to evolve, it has never […]

With tightening budgets and increasing pressure to de-risk R&D, pharma and biotech are shifting their focus toward smarter, more efficient drug design. Companies are investing more in enabling technologies—from computational modeling and AI-driven predictions to structural biology techniques like Cryo-EM, NMR, and X-ray crystallography—to improve rational drug design and enhance decision-making early in discovery. While […]

The Innovation in Psychosis Therapeutics Summit is the premier industry forum dedicated to advancing next-generation approaches for psychosis treatment. As 2025 marks a pivotal year for psychosis drug development—with a surge in clinical advancements and key collaborations gaining momentum—this inaugural event unites the brightest minds in biotech and pharma to overcome critical challenges in drug […]

With the autoimmune wave breathing financial life back into the allogeneic space, and a growing number of oncology pipelines entering the clinic, the allogeneic community are eagerly anticipating what lies ahead! Making now the ideal time to attend the 7th Annual Allogeneic Cell Therapies Summit (June 10-12 | Boston, MA), your flagship forum uniting the top allogeneic […]

This year’s IMPACCT Real World Evidence Europe conference is the only case-study led industry forum providing actionable insights into numerous challenges such as optimizing evidence generation plans in early stages, enhancing collaboration between industry and public research to advance RWE, consolidating cross-functional collaboration to improve effectiveness of RWE studies, and exploring actionable study designs that empower patients […]

Vendor management processes are crucial for ensuring compliance, quality, and timely delivery at every stage, serving as the backbone of successful clinical trials. Acknowledging the transformative impact, the industry is prioritizing the optimization of these intricate processes, making significant investments to enhance key functions, improve performance, and maintain a competitive edge. Despite this professionals managing […]

Linking the East to the West in the ADC World | 在ADC世界连接东西方 | ADC 세계에서 동서 연결하기ADCの世界で東西をつなぐ In 2025, Asia will continue leading ADC innovation, with growth in dual-payload ADCs, bispecific ADCs, and novel linker-payload technologies. Staying informed through clinical updates, connecting with new companies, and building collaborations will be key to seizing emerging opportunities. The […]

Returning for its 10th anniversary, the Microbiome Movement Summit remains the premier global gathering for microbiome drug developers, uniting experts across discovery, preclinical, translational, regulatory, and commercial sectors to drive innovation in the microbiome space. Connect with over 140+ experts from diverse fields within microbiome R&D, including representatives from Pulmobiotics, Seres Therapeutics, BiomeBank, and PharmaBiome. Engage in dynamic discussions, forge valuable partnerships, and gain actionable insights that will drive your microbiome […]

CPHI & PMEC China is Asia's premier pharmaceutical event for sourcing, networking, learning and innovation with over 20 years' experience of bringing together Chinese and global pharma professionals. CPHI & PMEC China 2025 will cover more than 230,000 square meters of exhibition area, attract over 90,000 global attendees and 3,500 exhibitors, and hold more than […]

The 5th Medical Device Software Development Summit is your must-attend opportunity to gain actionable strategies, real-world case studies, and expert insights to confidently develop, secure, and regulate cutting-edge medical device software - without compromise. Dedicated to navigating the complexities of US and global regulations, addressing cybersecurity vulnerabilities, and managing legacy device updates, this summit unites 120+ industry leaders […]

2024 saw a wealth of clinical progression with Nouscom, CureVac, Transgene and other pioneering companies paving the way for neoantigen based vaccines and therapies to become tolerable, durable medicines to effectively treat cancer. Ready to unite the global neoantigen community, the 8th International Neoantigen Summit 2025 returns to address key challenges in the discovery, translation […]

Coming to San Diego, CA for the first time, the 5th Induced Proximity-Based Drug Discovery Summit returns as your intimate learning and networking setting to cover the depth and breadth of proximity-based drugs from stabilization, phosphorylation and methylation to novel lysosome-based degradation to finally drug the undruggable. Enabling leaders in biopharma and academia to identify […]

The 4th Liquid Biopsy for Precision Oncology East Coast Summit returns to Boston with a refreshed agenda, sharpened focus, and a renewed mission: to accelerate access to more sensitive, less invasive testing by addressing the most pressing challenges across the entire patient care continuum. This year, we’ve updated the Summit’s name and expanded its scope. […]

The ESG in Life Sciences Summit West - Mastering ESG Compliance & Strategic Sustainability in Life Sciences in 2025. As ESG becomes a key differentiator for securing business and investment, life sciences companies are ramping up sustainability efforts - expanding teams, funding new initiatives, and integrating ESG into corporate strategy. Yet, with shifting global reporting […]

“Toxicity is the killer of ADCs” and remains the primary challenge limiting ADC success in the clinic. From unpredictable off-target effects to non-translating toxicity profiles and dose limiting toxicities, the industry must address key hurdles in preclinical models, patient selection, ADC design, and cross-disciplinary communication to accelerate the next wave of safer, more effective ADCs. The […]

The 3rd Obesity & Weight Loss Summit has been announced and is set to ignite the field.  The summit will unite experts to harness novel targets and GLP combination therapies to improve efficacy, tolerability, and longer lasting clinical outcomes. Join us at this unique, industry-led summit to: Discover groundbreaking combination therapies and novel targets to minimize and manage side […]

Building on recent breakthroughs in gene therapy, 2025 is poised for major advancements in cell transplants, gamma secretase inhibitors, anti-inflammatory programs, and more to address the growing unmet need for more transformative hearing loss treatments. With an aging population and an urgent need to restore a greater spectrum of hearing abilities beyond the scope of […]